Robert Thomas Freeman - 17 Jul 2024 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
19 Jul 2024, 20:22:08 UTC
Prior SEC filing
29 Mar 2024
Next SEC filing
06 Sep 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christopher J. Joyce, as Attorney-in-Fact, for Robert Thomas Freeman

Key filing fact

Robert Thomas Freeman filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 19 Jul 2024.

Key facts

  • This page summarizes Robert Thomas Freeman's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 19 Jul 2024, 20:22.

Change

  • Previous filing in this sequence was filed on 29 Mar 2024.
  • Current net transaction value: -$1,050,236.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALHC transaction

Common Stock

Sale

Transaction value
$221,013
Shares
-22,100
Change %
-4.3%
Price
$10.00
Shares after
497,329
Date
17 Jul 2024
Ownership
See Footnote
Footnotes
F1
ALHC transaction

Common Stock

Sale

Transaction value
$440,433
Shares
-44,042
Change %
-8.9%
Price
$10.00
Shares after
453,287
Date
18 Jul 2024
Ownership
See Footnote
Footnotes
F1
ALHC transaction

Common Stock

Sale

Transaction value
$388,790
Shares
-38,858
Change %
-8.6%
Price
$10.01
Shares after
414,429
Date
19 Jul 2024
Ownership
See Footnote
Footnotes
F1
ALHC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
865,407
Date
17 Jul 2024
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .